Development of novel attenuated PRRS vaccine and disease model.

PRRS被广泛认为是猪中最重要的经济疾病，据估计，仅在产量损失方面，全球生猪生产者每年就损失超过10亿GB。这些损失在很大程度上是由于未能开发和部署有效的疫苗。Cambivac的目标是生产更有效地控制疾病并能够对新出现的威胁做出快速反应的疫苗。我们相信，在这项研究中与莫雷登合作开发的技术，最终部署到有效的PRRSV疫苗上，可以为英国动物保健业带来可观的收入，并成为应对PRRS疾病带来的挑战的重要工具

PRRS is widely regarded as the most economically important disease in swine, estimated to cost global swine producers in excess of £1billion per annum in production losses alone. These losses are largely the result of a failure to develop and deploy effective vaccines. Cambivac aims to produce vaccines that more effectively control the disease and can respond rapidly to emerging threats. We believe the technology under development collaborating with Moredun in this study, ultimately deployed towards effective PRRSV vaccines could derive substantial earnings for the UK animal health industry and be an important tool to combat the challenges posed by PRRS disease